Literature DB >> 29619316

Pulmonary cryptococcal infection presenting with multiple lung nodules.

Thilini L Basnayake1,2, Aijye Lim3, Bart J Currie4,5.   

Abstract

Pulmonary infections from the environmental fungus Cryptococcus gattii (C. gattii) are notable for cryptococcomas, which are usually solitary and can be very large. As with infections with Cryptococcus neoformans (C. neoformans) patients can have concomitant cryptococcal meningitis; however, unlike for C. neoformans, infections with C. gattii often occur in immunocompetent patients. The highest published incidence of C. gattii infection has been in the Indigenous Australian population of Arnhem Land in the tropical north of the country. More recently C. gattii has been responsible for outbreaks of cryptococcosis in the Pacific Northwest of Canada and the United States of America (USA). A previously healthy Indigenous male from Arnhem Land presented with pulmonary cryptococcosis with chest imaging showing >50 bilateral lung nodules. This unusual occurrence was attributed to probable inhalation of fungal elements from prior use of a high-pressure leaf blower to clear eucalyptus and other debris in a remote bush camp.

Entities:  

Year:  2018        PMID: 29619316      PMCID: PMC5881413          DOI: 10.1016/j.rmcr.2018.01.011

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Cryptococcus gattii Cryptococcus neoformans Computed tomography Chest x-ray Human immunodeficiency virus Human T-lymphotropic virus 1 United States of America

Introduction

We present the case of an immunocompetent Indigenous Australian male with a clinical presentation and unusual radiological findings suggestive of pulmonary cryptococcosis consequent to massive inhalation of aerosolised fungal elements.

Case report

A 31-year-old previously fit Australian Indigenous male ranger from a remote community in Arnhem Land, Northern Territory Australia was admitted to Royal Darwin Hospital with a 2-week history of pleuritic chest pain, fevers and cough. Several days prior to symptom onset his work had included extensive use of a leaf blower for an environmental clean-up of the ranger camp, with likely exposure to considerable aerosols from debris from tropical savannah eucalypts. On arrival he was alert but tachypneic and febrile. He was haemodynamically stable and SpO2 was 98% on room air. Chest was resonant on percussion and clear on auscultation apart from a few left mid-lower zone crackles. Blood white cell count was 17.4 × 109/L (4.0–11.0) with 14.0 neutrophils and 1.8 lymphocytes. C-reactive protein was 279.4mg/L (0.0–5.0). His respiratory rate settled to normal over several hours without supplemental oxygen. Chest x-ray (CXR) and computed tomography (CT) chest revealed numerous bilateral lung nodules (>50) ranging in size from a few millimetres to several centimetres in diameter and also mediastinal and hilar lymphadenoapthy (Fig. 1a and b). Human immunodeficiency virus (HIV), human T-lymphotropic virus 1 (HTLV-1), serology for melioidosis and vasculitic screen were negative. Provisional diagnosis of metastatic malignancy was made but he was initially given ceftriaxone and gentamicin empirically. Histology of a CT-guided biopsy of a lung nodule showed yeasts in a background of chronic inflammation (Fig. 2a and b). Fungal culture confirmed the yeast to be C. gattii. Serum cryptococcal antigen was positive, titre 1:1024. Magnetic resonance imaging brain was normal, as was analysis of the cerebrospinal fluid (CSF), with negative CSF cryptococcal antigen. Once the biopsy result was available he was commenced on intravenous liposomal amphotericin and oral flucytosine. This was continued for 6 weeks, followed by oral fluconazole planned for 6 months. Repeat CT chest at 15 weeks showed significant reduction in the size and number of pulmonary lesions (Fig. 1c and d).
Fig. 1

CT chest at presentation (Fig. 1a and b) showing numerous, bilateral lung nodules of varying size and CT chest after 15 weeks of treatment (Fig. 1c and d) showing significant reduction in the size and number of pulmonary lesions, but not yet complete resolution.

Fig. 2

Histopathology of CT-guided biopsy of lung nodule from left lower lobe. a: H&E section demonstrating tissue necrosis with cryptococci (eosinophilic, thin-walled, round yeast forms surrounded by a polysaccharide capsule). b: Yeast cells are positive for D-PAS stain.

CT chest at presentation (Fig. 1a and b) showing numerous, bilateral lung nodules of varying size and CT chest after 15 weeks of treatment (Fig. 1c and d) showing significant reduction in the size and number of pulmonary lesions, but not yet complete resolution. Histopathology of CT-guided biopsy of lung nodule from left lower lobe. a: H&E section demonstrating tissue necrosis with cryptococci (eosinophilic, thin-walled, round yeast forms surrounded by a polysaccharide capsule). b: Yeast cells are positive for D-PAS stain.

Discussion

Cryptococcosis is disease of humans and animals caused by environmental basidiomycetous yeasts in the genus Cryptococcus [1]. The potential numerous pathogenic species are in two species complexes; the C. neoformans species complex and the C. gattii species complex [2,3]. C. neoformans is notable for causing meningitis in immunocompromised patients and being a major cause of death globally in those with untreated HIV infection. C. gattii has long been recognized as a cause of pulmonary disease (most notably large pulmonary cryptococcomas) and meningitis in immunocompetent patients in Australia, with the highest published incidence being in the Indigenous Australian population of Arnhem Land in the tropical north [[4], [5], [6]]. More recently C. gattii has been responsible for outbreaks of cryptococcosis in the Pacific Northwest of Canada and the United States of America (USA) [7]. The first isolation of C. gattii from the environment was from an Australian river red gum (Eucalyptus camaldulensis) [8]. Recent environmental sampling and genomic analysis of isolates from trees and patients in the Americas and globally has now resulted in substantial revisions to the earlier hypothesis that C. gattii originated in Australia and was possibly disseminated globally with export of eucalyptus trees [9]. It is now apparent that many other trees can also harbor C. gattii [10]. Recent molecular genomics shows the ancestral origin of C. gattii, including the lineages responsible for the Canadian and USA outbreaks, to be from South America [2]. Inoculation of the fungus is usually by inhalation, resulting in either asymptomatic infection or development of pulmonary disease [11]. Either can then lead to haematogenous spread to the central nervous system (meningitis and cryptococcomas), or less commonly other organs, such as bone or skin [11]. The commonest pulmonary finding with C. gattii is a single, two or several circumscribed cryptococcomas, both in those with combined pulmonary/central nervous system disease and in those with pulmonary infection alone [4,6]. Cryptococcomas may vary in size (range from approximately 1 to 7cm in diameter), with smooth or ill-defined edges, and have no specific lobar preference. [12,13] With even large cryptococcomas the patient may be asymptomatic. It is not uncommon for those with C. gattii meningitis to have few or no pulmonary symptoms, irrespective of the presence of pulmonary lesions. Treatment involves antifungal therapy and consideration of surgical resection in patients with large cryptococcomas [14]. Whilst there are many case reports of pulmonary cryptococcosis, to the best of our knowledge radiological presentation with as numerous a number of lung nodules of varying size such as in our patient (>50) has not been published previously. The Arnhem Land region in tropical Australia where the patient worked has the highest incidence of C. gattii infection documented globally, but no prior patient has presented with such extensive multiple cryptococcomas. The landscape he works in is dominated by tropical woodland and savannah and rocky escarpments. Of interest there are no E. camaldulensis in that region [15] but C. gattii has been recovered from the two dominant eucalypt species, E. tetrodonta (the Darwin stringybark) and E. miniata (the woollybutt) (unpublished data). The specific activity considered likely to have generated aerosols of fungal elements in quantity enough to cause such extensive inhalational disease was high-pressure leaf blowing whilst clearing a camp area.
  14 in total

1.  Cryptococcus neoformans var gattii.

Authors:  B Currie; T Vigus; G Leach; B Dwyer
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

2.  Natural habitat of Cryptococcus neoformans var. gattii.

Authors:  D H Ellis; T J Pfeiffer
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

Authors:  S Chen; T Sorrell; G Nimmo; B Speed; B Currie; D Ellis; D Marriott; T Pfeiffer; D Parr; K Byth
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

4.  Cryptococcosis in HIV negative patients: findings on chest radiography.

Authors:  D J Roebuck; D A Fisher; B J Currie
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 5.  Spread of Cryptococcus gattii into Pacific Northwest region of the United States.

Authors:  Kausik Datta; Karen H Bartlett; Rebecca Baer; Edmond Byrnes; Eleni Galanis; Joseph Heitman; Linda Hoang; Mira J Leslie; Laura MacDougall; Shelley S Magill; Muhammad G Morshed; Kieren A Marr
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

6.  Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes.

Authors:  D Fisher; J Burrow; D Lo; B Currie
Journal:  Aust N Z J Med       Date:  1993-12

7.  Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.

Authors:  Sharon C-A Chen; Tony M Korman; Monica A Slavin; Deborah Marriott; Karen Byth; Narin Bak; Bart J Currie; Krispin Hajkowicz; Christopher H Heath; Sarah Kidd; William J H McBride; Wieland Meyer; Ronan Murray; E Geoffrey Playford; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2013-05-22       Impact factor: 9.079

Review 8.  Ecology, life cycle, and infectious propagule of Cryptococcus neoformans.

Authors:  D H Ellis; T J Pfeiffer
Journal:  Lancet       Date:  1990-10-13       Impact factor: 79.321

9.  The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis.

Authors:  Kyung J Kwon-Chung; John E Bennett; Brian L Wickes; Wieland Meyer; Christina A Cuomo; Kurt R Wollenburg; Tihana A Bicanic; Elizabeth Castañeda; Yun C Chang; Jianghan Chen; Massimo Cogliati; Françoise Dromer; David Ellis; Scott G Filler; Matthew C Fisher; Thomas S Harrison; Steven M Holland; Shigeru Kohno; James W Kronstad; Marcia Lazera; Stuart M Levitz; Michail S Lionakis; Robin C May; Popchai Ngamskulrongroj; Peter G Pappas; John R Perfect; Volker Rickerts; Tania C Sorrell; Thomas J Walsh; Peter R Williamson; Jianping Xu; Adrian M Zelazny; Arturo Casadevall
Journal:  mSphere       Date:  2017-01-11       Impact factor: 4.389

10.  Projecting global occurrence of Cryptococcus gattii.

Authors:  Deborah J Springer; Vishnu Chaturvedi
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more
  1 in total

1.  Adjuvant Curdlan Contributes to Immunization against Cryptococcus gattii Infection in a Mouse Strain-Specific Manner.

Authors:  Patrícia Kellen Martins Oliveira-Brito; Gabriela Yamazaki de Campos; Júlia Garcia Guimarães; Letícia Serafim da Costa; Edanielle Silva de Moura; Javier Emílio Lazo-Chica; Maria Cristina Roque-Barreira; Thiago Aparecido da Silva
Journal:  Vaccines (Basel)       Date:  2022-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.